WitrynaIMS Health China to develop delivering professional training By Shan Juan (chinadaily.com.cn) Updated: 2011-04-06 14:32 WitrynaIMS Health predicts that pharmaceutical sales in China will increase from $65.77bn (2011) to reach $143bn by 2016. Likewise, it also anticipates that total sales in Brazil will almost double from $27.69bn (2011) to $52.94bn in the same period. Sales in Russia are expected to enjoy compound annual growth of 11.5 per cent in the next three years ...
IMS Health (China) - IMS Health - IMS Health LinkedIn - 领英
WitrynaIQVIA 中国. IQVIA艾昆纬是全球医疗健康行业的领导者,运用数据、技术、统计分析和人类智慧,助力我们的客户推动医疗卫生和人类健康的进步。. 携手同行,我们共创更 … WitrynaIn 2003, IMS Health sold its entire 56% stake in Cognizant and both companies are separated into two independent entities as IMS Health and Cognizant In 2004, United Research China Shanghai was acquired, providing coverage of China's consumer health market. In 2005, acquired PharMetrics, a U.S. provider of patient-centric … popsocket wireless charger
IMS Market Prognosis - IMS Health - YUMPU
WitrynaIMS Health Hospitals and Health Care Danbury, CT 158,259 followers Follow See all 4,807 employees About us IMS Health has now merged with Quintiles. Visit our new … Witryna9 wrz 2024 · Current success rates (from first-in-human to launch) are approximately 13 percent in oncology, with an average development timeline of 9.5 years. 9 Even after launch, there is wide disparity in outcomes: seven products with more than $5 billion make up 39 percent of 2024 revenues and more than half of the products launched … WitrynaChina already tops the emerging markets in terms of performance, and will top the global market by 2016, according to the data from IMS Health. China is not only the light of hope in the 'big depression' era, but also will be the strategic focus for the industry for decades to come. The megatrend – feeling the pulse of China shark air filter cleaning